Insights
ICH Good Clinical Practice (GCP) updates – reflections and recommendations
Nick Medhurst
In January 2025, the ICH made its finalised, updated GCP Principles and ‘Annex 1’ available to the public, due to become effective in Summer 2025. The ICH also consulted on a new 'Annex 2'.
The Collaborative submits commentary on draft ICH GCP Annex 2 Guideline to international regulators
Farida
The Good Clinical Trials Collaborative has submitted responses to the draft ICH Good Clinical Practices (Annex 2) guidelines to regulatory bodies around the world.
The Collaborative hosts a webinar with The Global Health Network on updated ICH GCP guidelines
Farida
The Collaborative hosted a webinar with The Global Health Network on 'Making good clinical trials easier & more equitable: Updated ICH GCP guidelines’. A recording of the event is now available online.
Good Trials Prism Partners Forum convenes in Switzerland
Farida
The Collaborative recently hosted a Good Trials Prism forum at the Brocher Foundation, Switzerland.
The WHO releases “Guidance for best practices for clinical trials” incorporating Collaborative principles
Farida
The World Health Organization (WHO) yesterday released its “Guidance for best practices for clinical trials”, which incorporates the principles established by the Good Clinical Trials Collaborative.
The Collaborative hosts a webinar with The Global Health Network
Farida
On 6th February, the Collaborative hosted a webinar with The Global Health Network on "Returning to the Principles of Good Randomized Clinical Trials". A recording of the event is now available online.
Inside GoodTrials Newsletter – February 2024
Farida
Highlights of this edition include an upcoming webinar hosted by the Good Clinical Trials Collaborative and The Global Health Network and the Collaborative’s recommendations to WHO and ICH clinical trials guidance consultations.
The Collaborative submits commentary on draft GCP E6R(3) guidelines to EMA
Ee Ching Tan
On 27 September, the Good Clinical Trials Collaborative submitted its commentary on the draft Good Clinical Practice (GCP) E6R(3) guidelines to the European Medicines Agency (EMA), in response to the public consultation launched by the International Council of Harmonisation of Technical Requirements for Pharmaceuticals for Human…
